MedPath

ONO-5788

Generic Name
ONO-5788

Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788

Phase 1
Completed
Conditions
Acromegaly
Interventions
Drug: [14C]-ONO-5788
First Posted Date
2019-02-21
Last Posted Date
2019-11-07
Lead Sponsor
Ono Pharmaceutical Co. Ltd
Target Recruit Count
12
Registration Number
NCT03849872
Locations
🇳🇱

PRA-EDS, Groningen, NZ, Netherlands

A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers

Phase 1
Terminated
Conditions
Acromegaly
Interventions
Drug: ONO-5788 Placebo
First Posted Date
2018-06-27
Last Posted Date
2019-06-05
Lead Sponsor
Ono Pharmaceutical Co. Ltd
Target Recruit Count
76
Registration Number
NCT03571594
Locations
🇺🇸

Celerion, Tempe, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath